Literature DB >> 11583970

Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.

M Wislez1, J Fleury-Feith, N Rabbe, J Moreau, D Cesari, B Milleron, C Mayaud, M Antoine, P Soler, J Cadranel.   

Abstract

We evaluated the role of the tumor environment in the regulation of apoptosis of tumor-infiltrating neutrophils, the number of which correlates negatively with outcome, in patients with adenocarcinoma of the bronchioloalveolar (BAC) subtype. We examined three different parameters of apoptosis, namely morphological aspect, annexin-V expression, and DNA fragmentation. Bronchoalveolar lavage fluid (BALF) supernatants from patients with BAC significantly inhibited the 24-hour spontaneous apoptosis of normal peripheral blood neutrophils in vitro compared to BALF supernatants from control patients (64 +/- 4% versus 90 +/- 2% measured by annexin-V flow cytometry, P = 0.04). The alveolar neutrophil count correlated positively with the granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) concentrations in the patient's BALF. Furthermore, neutralizing antibodies (Abs) against GM-CSF and G-CSF significantly inhibited BALF anti-apoptotic activity (15 to 40% and 34 to 63% inhibition, respectively), whereas neutralizing Abs against interleukin (IL)-8, IL-6, IL-1beta and tumor necrosis factor-alpha had no significant effect. In an attempt to identify the cell origin of anti-apoptotic cytokines, we tested in vitro the effect of BAC cells (A549 cell line and primary culture derived from a patient's BAC tumor) on the apoptosis of peripheral blood neutrophils. Cell-free supernatants from tumor cells did not inhibit neutrophil apoptosis. In contrast, cell-free supernatants from tumor cells previously exposed to conditioned media from peripheral blood mononuclear cells and alveolar macrophages significantly inhibited spontaneous neutrophil apoptosis. This inhibition was partially lifted when conditioned media from mononuclear cells were previously treated with Abs against IL-1beta and tumor necrosis factor-alpha. As in vivo, neutralizing Abs against GM-CSF significantly inhibited the anti-apoptotic activity of cell culture supernatants, and combination with Abs against G-CSF had an additive effect. In vivo, GM-CSF and G-CSF were strongly expressed by tumor cells and moderately or not expressed by the normal epithelium, as assessed by immunohistochemical studies. These findings demonstrate that the tumor environment generates local conditions that prolong alveolar neutrophil survival through the production of soluble factors, thereby contributing to the persistence of the neutrophil alveolitis observed in BAC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583970      PMCID: PMC1850503          DOI: 10.1016/S0002-9440(10)62529-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Granulocyte apoptosis and its role in the resolution and control of lung inflammation.

Authors:  C Haslett
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

2.  Bronchiolo-alveolar cell carcinoma diagnosed by bronchoalveolar lavage.

Authors:  S C Springmeyer; R Hackman; J J Carlson; J E McClellan
Journal:  Chest       Date:  1983-02       Impact factor: 9.410

3.  Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter.

Authors:  A Takise; T Kodama; Y Shimosato; S Watanabe; K Suemasu
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

4.  Postoperative T1 N0 non-small cell lung cancer. Squamous versus nonsquamous recurrences. The Lung Cancer Study Group.

Authors: 
Journal:  J Thorac Cardiovasc Surg       Date:  1987-09       Impact factor: 5.209

5.  Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.

Authors:  V L Roggli; R T Vollmer; S D Greenberg; M H McGavran; H J Spjut; R Yesner
Journal:  Hum Pathol       Date:  1985-06       Impact factor: 3.466

6.  Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells.

Authors:  T K Lee; R D Horner; J F Silverman; Y H Chen; C Jenny; C W Scarantino
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

7.  GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice.

Authors:  J A Huffman Reed; W R Rice; Z K Zsengellér; S E Wert; G Dranoff; J A Whitsett
Journal:  Am J Physiol       Date:  1997-10

8.  Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells.

Authors:  A B Weitberg; S A Weitzman; M Destrempes; S A Latt; T P Stossel
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

9.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers.

Authors:  Y Shimosato; A Suzuki; T Hashimoto; Y Nishiwaki; T Kodama; T Yoneyama; T Kameya
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394

10.  International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA.

Authors:  D L Davis; D Hoel; J Fox; A Lopez
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

View more
  12 in total

1.  Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.

Authors:  Elizabeth F Redente; David J Orlicky; Ronald J Bouchard; Alvin M Malkinson
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor.

Authors:  Kazuya Endo; Shunji Kohnoe; Takeshi Okamura; Masaru Haraguchi; Eisuke Adachi; Yasushi Toh; Hideo Baba; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  Preliminary experience with low concentration of granulocyte-macrophage colony-stimulating factor: a potential regulator in preimplantation mouse embryo development and apoptosis.

Authors:  Barry Behr; Stephen Mooney; Yan Wen; Mary Lake Polan; Hongbo Wang
Journal:  J Assist Reprod Genet       Date:  2005-01       Impact factor: 3.412

4.  Tumor-infiltrating neutrophils in pancreatic neoplasia.

Authors:  Michelle D Reid; Olca Basturk; Duangpen Thirabanjasak; Ralpha H Hruban; David S Klimstra; Pelin Bagci; Deniz Altinel; Volkan Adsay
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

5.  Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.

Authors:  Kentaro Iwanaga; Yanan Yang; Maria Gabriela Raso; Lijiang Ma; Amy E Hanna; Nishan Thilaganathan; Seyed Moghaddam; Christopher M Evans; Huaiguang Li; Wei-Wen Cai; Mitsuo Sato; John D Minna; Hong Wu; Chad J Creighton; Francesco J Demayo; Ignacio I Wistuba; Jonathan M Kurie
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

Review 6.  Tumor evasion from T cell surveillance.

Authors:  Katrin Töpfer; Stefanie Kempe; Nadja Müller; Marc Schmitz; Michael Bachmann; Marc Cartellieri; Gabriele Schackert; Achim Temme
Journal:  J Biomed Biotechnol       Date:  2011-11-15

7.  Imaging cell surface glycosylation in vivo using "double click" chemistry.

Authors:  André A Neves; Henning Stöckmann; Yelena A Wainman; Joe C-H Kuo; Sarah Fawcett; Finian J Leeper; Kevin M Brindle
Journal:  Bioconjug Chem       Date:  2013-05-16       Impact factor: 4.774

Review 8.  Role of infiltrated leucocytes in tumour growth and spread.

Authors:  E Y Lin; J W Pollard
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

Review 9.  The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.

Authors:  Natasha Ustyanovska Avtenyuk; Nienke Visser; Edwin Bremer; Valerie R Wiersma
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

10.  Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.

Authors:  Nicole K Yun; Sherin J Rouhani; Christine M Bestvina; Ethan M Ritz; Brendan A Gilmore; Imad Tarhoni; Jeffrey A Borgia; Marta Batus; Philip D Bonomi; Mary Jo Fidler
Journal:  Cancers (Basel)       Date:  2021-03-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.